Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
25,296,136
-
Total 13F shares
-
102,113
-
Share change
-
+71,339
-
Total reported value
-
$214,326
-
Price per share
-
$2.03
-
Number of holders
-
14
-
Value change
-
+$151,856
-
Number of buys
-
9
Institutional Holders of Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) as of Q2 2023
As of 30 Jun 2023,
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,113 shares.
The largest 10 holders included
VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., BANK OF MONTREAL /CAN/, Tower Research Capital LLC (TRC), EMFO, LLC, Newbridge Financial Services Group, Inc., GROUP ONE TRADING, L.P., and MORGAN STANLEY.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.